Tetryzoline

Tetryzoline
Clinical data
ATC code	R01AA06 (WHO) S01GA02 (WHO);
Identifiers
	IUPAC name (RS)-2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole;
CAS Number	84-22-0;
PubChem CID	5419;
ChemSpider	5226 ;
UNII	S9U025Y077;
KEGG	D08578 ;
ChEBI	CHEBI:28674 ;
ChEMBL	ChEMBL1266 ;
CompTox Dashboard (EPA)	DTXSID1047861 ;
ECHA InfoCard	100.001.384
Chemical and physical data
Formula	C13H16N2
Molar mass	200.285 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	117–119 °C (243–246 °F) 256–257 °C (493–495 °F) for HCl-salt
Solubility in water	Very soluble in water and ethanol, slightly soluble in chloroform and insoluble in diethylether
	SMILES N\1=C(\NCC/1)C3c2ccccc2CCC3;
	InChI InChI=1S/C13H16N2/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13/h1-2,4,6,12H,3,5,7-9H2,(H,14,15) ; Key:BYJAVTDNIXVSPW-UHFFFAOYSA-N ;
	(what is this?) (verify)

Tetryzoline (INN), also known as tetrahydrozoline, is a drug used in some over-the-counter eye drops and nasal sprays. Tetryzoline was patented in 1954, and came into medical use in 1959.

Clinical data

ATC code	R01AA06 (WHO) S01GA02 (WHO)
Identifiers
IUPAC name (RS)-2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole
CAS Number	84-22-0
PubChem CID	5419
ChemSpider	5226^Y
UNII	S9U025Y077
KEGG	D08578^Y
ChEBI	CHEBI:28674^Y
ChEMBL	ChEMBL1266^Y
CompTox Dashboard (EPA)	DTXSID1047861
ECHA InfoCard	100.001.384
Chemical and physical data
Formula	C₁₃H₁₆N₂
Molar mass	200.285 g·mol⁻¹
3D model (JSmol)	Interactive image
Melting point	117–119 °C (243–246 °F) 256–257 °C (493–495 °F) for HCl-salt
Solubility in water	Very soluble in water and ethanol, slightly soluble in chloroform and insoluble in diethylether
SMILES N\1=C(\NCC/1)C3c2ccccc2CCC3
InChI InChI=1S/C13H16N2/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13/h1-2,4,6,12H,3,5,7-9H2,(H,14,15)^Y Key:BYJAVTDNIXVSPW-UHFFFAOYSA-N^Y
^NY (what is this?) (verify)